Tag Archive for: awakn

Psychedelic Clinical Trials

Three Phase 3 Clinical Trials that Could Legalize Psychedelics

The road to psychedelic legalization has many paths. These 3 clinical trials have the best chances to legalize psychedelics for therapy
Psychedelic Stocks Compass Small Pharma Mydecine Awakn

A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial

Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new research
Why Wednesday Will Be Biggest Day for Psychedelic Investors of 2022Shutterstock

Why Wednesday Will Be Biggest Day of 2022 for Psychedelic Investors

Psychedelic investors are about to see pivotal data presented on flagship programs by the titans of the psychedelics industry.
Top 5 Most Influential Psychedelic StudiesShutterstock

Top 5 Most Influential Psychedelic Studies

We unpack five of the most important psychedelic studies conducted in recent years as psychedelics become mainstream medicine.